Maher Albitar
57Patents
6h-index
12Co-inventors
69Inventor score
Filing activity: Sep 20, 2002 → May 1, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9546404B2 | Methods for detecting gene dysregulation by intragenic differential expression | Chemistry; Metallurgy | 14 | Active |
| US8093063B2 | Assay for detecting genetic abnormalities in genomic nucleic acids | Emerging Cross-Sectional Technologies | 12 | Active |
| US8815516B2 | Methods for detecting gene dysregulation by intragenic differential expression | Chemistry; Metallurgy | 10 | Active |
| US8426133B2 | Methods for detecting gene dysregulation by intragenic differential expression | Chemistry; Metallurgy | 10 | Active |
| US7943332B2 | Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays | Emerging Cross-Sectional Technologies | 7 | Active |
| US7718387B2 | Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays | Emerging Cross-Sectional Technologies | 7 | Active |
| US8114618B2 | Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays | Emerging Cross-Sectional Technologies | 5 | Active |
| US9175350B2 | EML4-ALK translocations in lung cancer | Chemistry; Metallurgy | 4 | Active |
| US9187788B2 | Methods for detecting gene dysregulation by intragenic differential expression | Chemistry; Metallurgy | 4 | Active |
| US10093980B2 | BCR-ABL truncation mutations | Physics | 4 | Active |
| US8232068B2 | Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays | Emerging Cross-Sectional Technologies | 4 | Active |
| US9488656B2 | BCR-ABL truncation mutations | Physics | 4 | Active |
| US9702877B2 | BCR-ABL variants | Chemistry; Metallurgy | 4 | Active |
| US8512948B2 | Compositions and methods for detecting mutations in JAK2 nucleic acid | Physics | 3 | Active |
| US8501423B2 | Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays | Emerging Cross-Sectional Technologies | 3 | Active |
| US9378407B2 | Automated fish reader using learning machines | Physics | 3 | Active |
| US9957573B2 | EML4-ALK translocations in lung cancer | Chemistry; Metallurgy | 2 | Active |
| US8790882B2 | Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays | Emerging Cross-Sectional Technologies | 2 | Active |
| US10100365B2 | Compositions and methods for detecting mutations in JAK2 nucleic acid | Physics | 2 | Active |
| US11345964B2 | BCR-ABL truncation mutations | Physics | 2 | Active |
| US10435758B2 | EML4-ALK translocations in lung cancer | Chemistry; Metallurgy | 2 | Active |
| US7622306B2 | Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies | Emerging Cross-Sectional Technologies | 1 | Expired |
| US11639529B2 | EML4-ALK translocations in lung cancer | Chemistry; Metallurgy | 1 | Active |
| US9336430B2 | Computer-assisted karyotyping | Physics | 1 | Active |
| US10954569B2 | Compositions and methods for detecting mutations in JAK2 nucleic acid | Physics | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.